Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

NodeGuardian · 2026-04-10T11:25:03+00:00

Plus Therapeutics, Inc. granted inducement awards of stock options and restricted stock units to two new employees under its 2015 Incentive Plan, approved by the Compensation Committee to attract talent, with vesting contingent on continued employment.

NodeGuardian

2026-04-10 11:25:03

Abstract generation in progress

Plus Therapeutics, Inc. announced the granting of inducement awards to two new employees. These awards, consisting of stock options and restricted stock units, were issued under the Company’s 2015 New Employee Incentive Plan and approved by the Compensation Committee as required by Nasdaq Rule 5635©(4) to entice new talent. The awards vest over several years, contingent on continued employment.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.